Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check6 days agoChange DetectedA new revision entry, v3.3.2, was added to the Study Record Versions, replacing the previous v3.3.1. This update pertains to the page's revision history and does not change the study data or visible content.SummaryDifference0.1%

- Check13 days agoChange Detected- The record history now shows a new revision v3.3.1 and removes v3.2.0. - This update affects only version history metadata and does not modify study data or status.SummaryDifference0.1%

- Check20 days agoChange DetectedDeletion removes a general site-wide notice about government funding and operating status from the page. The core content and history records remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedNo additions or deletions were detected on the page. The Record History shows no new changes in this view.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated operating status and funding caveat, with new verification details and a newer revision tag; previous recruitment status and older revision were removed.SummaryDifference16%

- Check70 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.